Effect of Fluosol‐DA/O2 on tumor‐cell and bone‐marrow cytotoxicity of nitrosoureas in mice bearing FSA‐II fibrosarcoma

B. Teicher,S. Holden,C. Rose

DOI: https://doi.org/10.1002/ijc.2910380220

1986-08-15

International Journal of Cancer

Abstract:The perfluorochemical emulsion, Fluosol‐DA, combined with carbogen breathing, potentiates the effects of radiation and a number of chemotherapeutic agents in several rodent tumors. The interaction of Fluosol‐DA with drugs may be quite complex. In addition to increasing the oxygen supply in the tumor, Fluosol‐DA may alter the pharmacokinetics of the drug and function as a drug delivery system. A series of 4 nitrosoureas of varying lipophilicity were administered as single doses intravenously (i.v.) to C3H/Be/FeJ mice bearing subcutaneous FSa‐11C fibro sarcomas. Doses of 40 mg/kg of CCNU, 15 mg/kg of BCNU, 20 mg/kg of MeCCNU and 15 mg/kg of chlorozoticin followed by 2 hr of breathing 95% oxygen produced tumor growth delays of 7.5, 4.0, 3.8 and 2.7 days, respectively. When the drug injection was followed immediately by 0.3 ml of Fluosol‐DA and 2 hr of breathing 95% oxygen, the tumor growth delay produced by CCNU, BCNU, MeCCNU and chlorozoticin increased 2‐fold, 10‐fold, 4.5‐fold and 3.5‐fold, respectively. Administration of the drugs in Fluosol‐DA followed by 2 hr of 95% oxygen breathing resulted in a 3.5‐fold increase in tumor growth delay with CCNU, a 17‐fold increase with BCNU, a 12.5‐fold increase with MeCCNU and a 6‐fold increase with chlorozoticin compared to drug and 95% oxygen breathing. These results are quantified in terms of cell survival by the tumor excision assay. Effects on the bone marrow from each treatment were measured using the granulocyte‐monocyte colony‐forming units (CFU‐GM) assay. There was no correlation between the lipophilicity of the nitro sources tested and the tumor growth delay produced by each treatment.